孕母糖尿病、胎儿生长与死产风险:澳大利亚维多利亚州全人群回顾性队列研究
该研究基于2009–2020年澳大利亚维多利亚州全部单胎分娩数据,分析孕期糖尿病与出生体重及死产风险的关系。结果显示妊娠期糖尿病与较低的死产风险相关,而孕前糖尿病与死产风险升高相关,尤其在出生体重>97百分位的巨大儿中风险更高。
要点
- 妊娠期糖尿病(饮食控制RR 0.75,胰岛素控制RR 0.37)与较低死产风险相关。
- 孕前糖尿病与死产风险升高相关(RR 2.68),各孕周及体重均持续。
- 出生体重>97百分位的孕前糖尿病胎儿死产风险尤其高。
核心结论
- 妊娠期糖尿病与较低的死产风险相关,可能归因于加强监测和提前医源性分娩。
- 孕前糖尿病与较高的总体死产风险相关,且在各孕周和出生体重中持续存在。
研究设计与样本
- 基于澳大利亚维多利亚州2009–2020年所有单胎分娩的回顾性队列研究,共纳入860,042例,其中100,856例(11.7%)合并孕期糖尿病。
主要发现
- 孕期糖尿病组分娩中位孕周为38.7周,无糖尿病组为39.4周;医源性分娩比例分别为65%和44%。
- 与无糖尿病相比,饮食控制妊娠期糖尿病的死产相对风险为0.75(95% CI 0.64-0.89),胰岛素控制者为0.37(95% CI 0.25-0.50)。
- 孕前糖尿病与死产风险升高相关(RR 2.68,95% CI 2.01-3.56)。
- 出生体重>97百分位的1型糖尿病婴儿死产RR为3.96(95% CI 1.23-12.76),2型糖尿病为4.02(95% CI 1.71-9.47)。
临床怎么用
- 对孕前糖尿病合并巨大儿(出生体重>97百分位)者应加强监测。
- 妊娠期糖尿病死产风险较低可能与监测加强和提前分娩有关,需权衡医源性早产风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the relationships between diabetes in pregnancy, birth weight, and stillbirth risk, using population-based data. RESEARCH DESIGN AND METHODS: All singleton births in Victoria, Australia, between 2009 and 2020 were linked with perinatal and diabetes data. For each diabetes subgroup (type 1, type 2, and gestational diabetes [diet-controlled, insulin-controlled]), we assessed the proportion of infants with a birth weight in <10th or >97th centile, the probability of stillbirth by birth weight centile, and stillbirth rate per 1,000 pregnancies across gestational age. RESULTS: Our study cohort of 860,042 included 100,856 pregnancies (11.7%) complicated by diabetes in pregnancy. Compared with no diabetes, women with diabetes in pregnancy gave birth earlier (median gestation 38.7 weeks vs. 39.4) and had more iatrogenic births (65% vs. 44%). Gestational diabetes was associated with a lower overall risk of stillbirth compared with no diabetes (diet-controlled: relative risk [RR] 0.75 [95% CI 0.64-0.89]; insulin-controlled: RR 0.37 [95% CI 0.25-0.50]). Compared with no diabetes, preexisting diabetes was associated with an increased risk of stillbirth (RR 2.68 [95% CI 2.01-3.56]), with this trend persisting across all gestational ages and birth weights. This was particularly observed among infants in the >97th centile (type 1 diabetes: RR 3.96 [95% CI 1.23-12.76]; type 2 diabetes: RR 4.02 [95% CI 1.71-9.47]). CONCLUSIONS: In our cohort, gestational diabetes was associated with a lower stillbirth risk compared with no diabetes, which potentially can be explained by increased monitoring and earlier iatrogenic delivery. Preexisting diabetes was associated with a higher overall risk of stillbirth, with macrosomic fetuses in the >97th centile representing a particularly high-risk group requiring close monitoring.
引用
- Gordon HG, Shub A, Walker SP, et al. Maternal Diabetes, Fetal Growth, and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia. Diabetes Care. 2025. PMID: 40902109. doi:10.2337/dc25-0833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。